Literature DB >> 11122113

Spontaneous regression of congenital leukaemia with an 8;16 translocation.

M Weintraub1, C Kaplinsky, N Amariglio, E Rosner, F Brok-Simoni, G Rechavi.   

Abstract

Congenital leukaemia (CL) is a rare disorder that presents with extramedullary infiltrates and a myeloid phenotype. CL can progress rapidly without adequate treatment, but, paradoxically, may also remit spontaneously. Because of the significant toxicity involved in delivering chemotherapy to newborns, it is important to identify those newborns who may not require treatment. We describe an infant who presented at 1 week of age with congenital myeloid leukaemia. Cytogenetic analysis revealed a t(8;16)(q11;p13) translocation. The infant's leukaemia underwent a spontaneous regression. This case further confirms the possibility of spontaneous remission in congenital leukaemia. Moreover, it suggests that the presence of a clonal cytogenetic aberration does not preclude the possibility of a spontaneous regression in CL.

Entities:  

Mesh:

Year:  2000        PMID: 11122113     DOI: 10.1046/j.1365-2141.2000.02356.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Clinico-hematological profile of congenital leukemia.

Authors:  Shashi Narayan; Sunita Sharma; Jagdish Chandra; Ritu Kulshreshtha
Journal:  Indian J Pediatr       Date:  2004-10       Impact factor: 1.967

Review 2.  Congenital acute myeloid leukemia with t(8;16) and t(17;19) double translocation: case presentation and literature review.

Authors:  Tae-Jung Sung; Dae-Hyoung Lee; Soon-Ki Kim; Yong-Hoon Jun
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

3.  Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis.

Authors:  Adi Diab; Lynette Zickl; Omar Abdel-Wahab; Suresh Jhanwar; Manjit A Gulam; Katherine S Panageas; Jay P Patel; Joseph Jurcic; Peter Maslak; Elisabeth Paietta; James K Mangan; Martin Carroll; Hugo F Fernandez; Julie Teruya-Feldstein; Selina M Luger; Dan Douer; Mark R Litzow; Hillard M Lazarus; Jacob M Rowe; Ross L Levine; Martin S Tallman
Journal:  Leuk Res       Date:  2012-10-24       Impact factor: 3.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.